Sterling Capital Management
CAPR icon

Sterling Capital Management’s Capricor Therapeutics CAPR Stock Holding History

Sterling Capital Management’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$16.7K Buy
1,764
+1,575
+833% +$17.4K ﹤0.01% 2288
2026
Q2 		$4.55K Sell
189
-94
-33% -$2.85K ﹤0.01% 2668
2026
Q1 		$8.6K Buy
283
+22
+8% +$586 ﹤0.01% 2457
2025
Q4 		$7.53K Buy
261
+168
+181% +$2.19K ﹤0.01% 2741
2025
Q3 		$671 Hold
93
– – ﹤0.01% 3134
2025
Q2 		$923 Sell
93
-39
-30% -$412 ﹤0.01% 3074
2025
Q1 		$1.25K Sell
132
-37
-22% -$514 ﹤0.01% 2740
2024
Q4 		$2.33K Buy
169
+135
+397% +$2.37K ﹤0.01% 2741
2024
Q3 		$517 Buy
+34
New +$168 ﹤0.01% 2855

Other funds holding CAPR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
HBK Sorce Advisory
HBK Sorce Advisory Erie, Pennsylvania $5.18B AUM 12.38% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Black Diamond Financial
Black Diamond Financial Towson, Maryland $1.18B AUM 15.24% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Sterling Capital Management's CAPR Position: Q3 2026 in Review

Sterling Capital Management increased its Capricor Therapeutics (CAPR) stake by 833% in Q3 2026, buying an estimated $17.4K and bringing the position to 1,764 shares worth $16.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2288.

Sterling Capital Management first reported a position in CAPR in Q3 2024 and has held it in 9 quarters since. 48 funds tracked by Wall St. Rank hold CAPR as of Q3 2026.

  • Sterling Capital Management held 1,764 shares of Capricor Therapeutics worth $16.7K as of Q3 2026.
  • Sterling Capital Management bought 1,575 Capricor Therapeutics shares in Q3 2026, an estimated $17.4K.
  • Capricor Therapeutics made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2288 holding.
  • Sterling Capital Management first reported a position in Capricor Therapeutics in Q3 2024 and has held it in 9 quarters since.
  • 48 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.